BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29348788)

  • 1. The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy.
    Roininen N; Haapasaari KM; Karihtala P
    Oxid Med Cell Longev; 2017; 2017():2908039. PubMed ID: 29348788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin diminishes the unfavourable impact of Nrf2 in breast cancer patients with type 2 diabetes.
    Urpilainen E; Kangaskokko J; Puistola U; Karihtala P
    Tumour Biol; 2019 Jan; 41(1):1010428318815413. PubMed ID: 30803422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of MGMT, hMLH1, hMSH2 and BRCA1 protein expression for pathological complete response to neoadjuvant chemotherapy in basal-like breast cancer patients.
    Nakai K; Mitomi H; Alkam Y; Arakawa A; Yao T; Tokuda E; Saito M; Kasumi F
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):923-30. PubMed ID: 22083523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation rate and breast cancer subtype, but not ALDH1 expression, predict pathological response to neoadjuvant chemotherapy in locally advanced breast cancer.
    Chatterjee D; Bal A; Das A; Singh G
    Virchows Arch; 2015 Sep; 467(3):303-10. PubMed ID: 26063415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma.
    Soini Y; Haapasaari KM; Vaarala MH; Turpeenniemi-Hujanen T; Kärjä V; Karihtala P
    Int J Clin Exp Pathol; 2011 Mar; 4(3):267-75. PubMed ID: 21487522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic Safety of Immediate Breast Reconstruction in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy: Short-Term Outcomes of a Matched Case-Control Study.
    Ryu JM; Park S; Paik HJ; Nam SJ; Kim SW; Lee SK; Yu J; Bae SY; Kim I; Bang SI; Mun GH; Pyon JK; Jeon BJ; Lee JE
    Clin Breast Cancer; 2017 Jun; 17(3):204-210. PubMed ID: 28065399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of serum miR34a expression during neoadjuvant chemotherapy predict the treatment response and prognosis in stage II/III breast cancer.
    Liu B; Su F; Li Y; Qi X; Liu X; Liang W; You K; Zhang Y; Zhang J
    Biomed Pharmacother; 2017 Apr; 88():911-917. PubMed ID: 28178621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant induction chemotherapy.
    Schwartz G
    Minerva Ginecol; 2005 Jun; 57(3):327-48. PubMed ID: 16166939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.
    Avci N; Deligonul A; Tolunay S; Cubukcu E; Fatih Olmez O; Ulas A; Hartavi M; Kurt E; Evrensel T
    J BUON; 2015; 20(1):45-9. PubMed ID: 25778295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keap1 expression has independent prognostic value in pancreatic adenocarcinomas.
    Isohookana J; Haapasaari KM; Soini Y; Karihtala P
    Diagn Pathol; 2015 Apr; 10():28. PubMed ID: 25879528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-Like Receptor 9 Expression Levels in Breast Carcinoma Correlate with Improved Overall Survival in Patients Treated with Neoadjuvant Chemotherapy and Could Serve as a Prognostic Marker.
    Singh A; Bandyopadhyay A; Mukherjee N; Basu A
    Genet Test Mol Biomarkers; 2021 Jan; 25(1):12-19. PubMed ID: 33372855
    [No Abstract]   [Full Text] [Related]  

  • 12. 15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer.
    Hu M; Li K; Maskey N; Xu Z; Peng C; Tian S; Li Y; Yang G
    Int J Clin Exp Pathol; 2015; 8(6):6910-8. PubMed ID: 26261578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy.
    Kasimir-Bauer S; Bittner AK; König L; Reiter K; Keller T; Kimmig R; Hoffmann O
    Breast Cancer Res; 2016 Feb; 18(1):20. PubMed ID: 26868521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic alterations in breast cancer associated with neoadjuvant chemotherapy: A comparison with baseline rates of change.
    Hariri N; Roma AA; Hasteh F; Walavalkar V; Fadare O
    Ann Diagn Pathol; 2017 Dec; 31():14-19. PubMed ID: 29146052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy.
    Promberger R; Dubsky P; Mittlböck M; Ott J; Singer C; Seemann R; Exner R; Panhofer P; Steger G; Bergen E; Gnant M; Jakesz R; Bago-Horvath Z; Rudas M; Bartsch R
    Clin Breast Cancer; 2015 Dec; 15(6):505-11. PubMed ID: 26195436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery following neoadjuvant chemotherapy for HER2-positive locally advanced breast cancer. Time to reconsider the standard attitude.
    Debled M; MacGrogan G; Breton-Callu C; Ferron S; Hurtevent G; Fournier M; Bourdarias L; Bonnefoi H; Mauriac L; Tunon de Lara C
    Eur J Cancer; 2015 Apr; 51(6):697-704. PubMed ID: 25704790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of tumor lymphocytic infiltrates in patients with breast cancer undergoing neoadjuvant chemotherapy.
    Avci N; Deligonul A; Tolunay S; Cubukcu E; Fatih Olmez O; Altmisdortoglu O; Tanriverdi O; Aksoy A; Kurt E; Evrensel T
    J BUON; 2015; 20(4):994-1000. PubMed ID: 26416041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential markers related to neoadjuvant chemotherapy sensitivity of breast cancer by SELDI-TOF MS.
    Zhang K; Yuan K; Wu H; Li Q; Wang Y; Chen S; Zhang L; Gu H; Fu R
    Appl Biochem Biotechnol; 2012 Feb; 166(3):753-63. PubMed ID: 22127810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of predictive markers of response to neoadjuvant chemotherapy in breast cancer.
    Tewari M; Pradhan S; Singh U; Singh TB; Shukla HS
    Asian J Surg; 2010 Oct; 33(4):157-67. PubMed ID: 21377101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer.
    Rouzier R; Pusztai L; Garbay JR; Delaloge S; Hunt KK; Hortobagyi GN; Berry D; Kuerer HM
    Cancer; 2006 Oct; 107(7):1459-66. PubMed ID: 16948128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.